Published the 11 December 2020Invent Medic today publishes a new edition of the company’s newsletter aimed at shareholders, investors, and other stakeholders. In this edition, CEO Karin Bryder comments that the company has been preparing for the submission for market registration of Efemia...
Published the 27 October 2020Solid sales in Sweden and Norway, while other markets are still affected by the corona pandemic FIRST NINE MONTHS (January–September 2020) The company’s sales amounted to 1,161 (248) KSEK. Other operating income amounted to 13 (0) KSEK. Operating costs amounted to...
Published the 22 October 2020Invent Medic announces that the company has appointed EMERGO by UL as its US representative in FDA-related matters, including the company’s upcoming 510(k) application for Efemia bladder support. As previously stated, Invent Medic is planning to submit a so-called...
Published the 4 October 2020Invent Medic Sweden AB announces that its distributor Arteriomed GmbH has received information from The National Association of Health Insurance Funds GKV that it will, from October 15 2020, include Invent Medic’s first product Efemia bladder support in the list of...
Published the 21 September 2020Today, Invent Medic publishes a new issue of the company’s newsletter aimed at shareholders, investors and other interested parties. In this issue, CEO Karin Bryder comments on the positive trend for the company’s product Efemia in Sweden and Norway, where an...
Published the 14 September 2020Invent Medic announces that the Swedish pharmacy chain Kronans Apotek will include the product Efemia bladder support in its online assortment. Efemia will become available to buy on kronansapotek.se in October 2020. With this agreement, Efemia will soon be available...
Published the 25 August 2020Invent Medic Sweden AB announces that the MAR label in the company’s Q2 report was missing. Invent Medic Sweden AB publishes an updated quarterly report with correction, when the MAR label in the earlier report was missing.
Published the 25 August 2020Continued sales growth despite Covid-19 shutdowns in the UK and Germany FIRST HALF OF THE YEAR (January-June) · The company’s sales amounted to 873 (218) KSEK. · Operating costs amounted to 8,300 (6,333) KSEK. · Result before and after tax amounted to -7,545 (-6,116)...
Published the 3 July 2020Invent Medic announces that the company has signed an agreement with the Swedish online pharmacy Apotea for the inclusion of the product Efemia bladder support in Apotea’s assortment. Efemia will become available to buy on apotea.se during the summer. With this...
Published the 18 June 2020Today, Invent Medic publishes a new issue of the company’s newsletter aimed at shareholders, investors and other interested parties. In this issue, CEO Karin Bryder informs that ongoing procurement processes and negotiations with Swedish healthcare regions continued...
